Aragen Life Sciences Limited, a active public limited company, was established on 07 December 2000 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the manufacturing sector, it holds CIN: U74999TG2000PLC035826. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹250.00 Cr and a paid-up capital of ₹216.99 Cr.
Formerly known as Gvk Biosciences Private Limited. It upholds a compliant status. Employing 3,859 professional, Its leadership includes Davinder Singh Brar (Director), Amit Varma (Director), Ajay Srivastava (Director). Past directors included Tarun Khanna, Venkata Krishna Reddy Gunupati, Indira Krishna Reddy Gunupati. It holds ₹583.80 Cr open charges and ₹768.38 Cr settled loans. Its latest AGM occurred on 27 June 2025, with the balance sheet filed on 31 March 2024. It is based at Plot 28A, Ida Nacharam,, Hyderabad, Telangana, 500076.
U74999TG2000PLC035826
035826
07 December 2000
₹250.00 Cr
₹216.99 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Aragen Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Davinder Singh Brar | Director | 26 Jul 2004 | Current |
| Amit Varma | Director | 09 Jan 2025 | Current |
| Ajay Srivastava | Director | 20 May 2021 | Current |
| Anita Ramachandran | Director | 07 Nov 2022 | Current |
| Rajat Sood | Director | 19 May 2021 | Current |
| Manmahesh Kantipudi | Ceo | 25 Jan 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Feb 2018 | Past |
| Pramod Abcsdd | Director | 30 Mar 2005 | Past |
| Pramod Abcsdd | Director | 01 Jun 2022 | Past |
| Pramod Abcsdd | Additional Director | 08 Nov 2007 | Past |
| Pramod Abcsdd | Director | 01 Jul 2007 | Past |
| Pramod Abcsdd | Director | 01 Sep 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aragen Life Sciences Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 6.42% decrease. The company also saw a substantial fall in profitability, with a 25.07% decrease in profit. The company's net worth Soared by an impressive increase of 13.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Aragen Life Sciences had a promoter holding of 67.41% and a public holding of 32.59%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,838,000,000.00
₹7,683,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Apr 2025 | Citi Bank N.A. | ₹100.00 Cr | Open |
| 28 Mar 2024 | Others | ₹50.00 Cr | Open |
| 07 Dec 2021 | Citi Bank N.A. | ₹50.00 Cr | Open |
| 08 Nov 2021 | Others | ₹100.00 Cr | Open |
| 31 Mar 2020 | Others | ₹75.00 Cr | Open |
Explore comprehensive loan charge details -
Aragen Life Sciences has a workforce of 3859 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aragen Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aragen Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 17 Aug 2023 via Charge ID 100774202 with Citi Bank N.A. was fully satisfied on 20 Sep 2025. was documented.
Progress on Aragen Life Sciences Limited last Annual general meeting of members was held on 27 Jun 2025 as per latest MCA records. was documented.
A charge with Citi Bank N.A. amounted to Rs. 100.00 Cr with Charge ID 101090128 was registered on 15 Apr 2025. was recorded as a recent event.
The activity A charge with Others of Rs. 100.00 Cr registered on 08 Nov 2021 with Charge ID 100505209 was modified on 26 Mar 2025. was completed.
A charge registered on 10 Feb 2022 via Charge ID 100558920 with Idbi Trusteeship Services Limited was fully satisfied on 20 Mar 2025. was recorded as a recent event.
Amit Varma was appointed as a Director was appointed as a Director on 09 Jan 2025 & has been associated with this company since 10 months 23 days . was recorded as a recent event.
Hyderabad is getting a big boost in the pharma industry with Aragen Life Sciences investing Rs 2000 crore and creating 1500 jobs. This will make the city a top destination for drug discovery and development. CM Revanth Reddy's leadership is attracting big investments and showcasing our talent. Aragen's CEO is confident in Hyderabad's potential and plans to invest for the next 5 years..
/PRNewswire-PRWeb/ -- Discover an informative webinar delving into the evolution of vaccine platform technologies to the current era of mRNA vaccines, with a....
The focus will be to develop talent in the areas of Synthetic Organic Chemistry and Analytical Chemistry CSIR- Indian Institute of Chemical Technology (CSIR-IICT), Aragen Life Sciences and Kewaunee La.
The CIN of Aragen Life Sciences Limited is U74999TG2000PLC035826.
Aragen Life Sciences Limited is headquartered at Plot 28A, Ida Nacharam,, Hyderabad, Telangana, 500076.
Aragen Life Sciences Limited was incorporated on 07 December 2000.
The current directors of Aragen Life Sciences Limited are
The primary industry of Aragen Life Sciences Limited is Manufacturing.
Aragen Life Sciences Limited is unlisted.
The authorized capital of Aragen Life Sciences Limited is ₹250.00 Cr, and the paid-up capital is ₹216.99 Cr.
The compliance status of Aragen Life Sciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX